Roche Diagnostics Belgium
- Company typePrivate
- Founded1896
- HeadquartersBrussels, Belgium
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
Roche Diagnostics Belgium firmographics
Firmographics- Name
- Roche Diagnostics Belgium
- Legal name
- NV Roche SA
- Website
- https://roche.be
- Company type
- Private
- Founded year
- 1896
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Roche Diagnostics Belgium industry classification
Industry- Product category
- Clinical Diagnostics
- NAICS
- Pharmaceutical and Medicine Manufacturing (32541), In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511)
- SIC
- Pharmaceutical Preparations (2834), In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Oncology Specialty Pharmaceuticals (HLAIACAA)
- akta.pro secondary industries
- Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Clinical Research & Trial Central Laboratories (HLAFAMAL)
Keywords
Where Roche Diagnostics Belgium is headquartered
LocationHeadquarters
- HQ city
- Brussels
- HQ country
- Belgium
- HQ region
- Europe
Offices2 records
Markets served
Roche Diagnostics Belgium business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Diagnostic Solutions: In-vitro diagnostics products and solutions covering screening, prevention, diagnosis, and disease monitoring for improved patient health outcomes and quality of life
- Pharmaceutical Products: Innovative medicines addressing unmet medical needs across therapeutic areas including oncology, with prescription medicines subject to regulatory approval and reimbursement frameworks
- Diabetes Care: Diabetes management devices including blood glucose meters and insulin pumps through Roche Diabetes Care Belgium
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
Roche Diagnostics Belgium product offering
Product offeringCore offering
Roche Diagnostics Belgium sells in-vitro diagnostic products and solutions covering screening, prevention, diagnosis, and disease monitoring, alongside innovative pharmaceutical medicines addressing unmet medical needs (notably in oncology). The portfolio also includes Roche Diabetes Care Belgium devices such as Accu-Chek blood glucose meters and insulin pumps. The company operates dedicated portals (RochePro, Navify) and a regional customer support center to serve healthcare providers, laboratories, hospitals, and patients across Belgium and Luxembourg.
Product overview
Roche Diagnostics Belgium operates as part of the Roche Group in Belgium, offering a dual expertise in pharmaceuticals and diagnostics to enable personalized healthcare. The portfolio includes Roche Diabetes Care Belgium (Accu-Chek devices for blood glucose monitoring and insulin pumps), the RochePro Portal for healthcare professionals, and comprehensive diagnostic solutions spanning screening, prevention, diagnosis, and disease treatment monitoring. The company leverages its combined pharmaceutical and diagnostic capabilities to improve quality and life expectancy through the right diagnosis, right treatment, at the right time, for the right patient.
Differentiator
Problem solved
Functional benefit
Brands
- RochePro: Portal for healthcare professionals providing resources and support for their practice
- Roche Diabetes Care Belgium
Products and services
- Roche Diagnostics Solutions In-vitro diagnostic products and solutions covering screening, prevention, diagnosis, treatment selection, and disease monitoring, serving healthcare providers, laboratories, and hospitals across Belgium and Luxembourg.
- Accu-Chek Diabetes Management Devices (Roche Diabetes Care Belgium) Accu-Chek branded blood glucose meters and insulin pumps for diabetes self-monitoring and insulin delivery, distributed in Belgium through Roche Diabetes Care Belgium via pharmacy and healthcare outlet networks plus a dedicated service line.
- Roche Pharmaceuticals (Oncology and Other Innovative Medicines) Innovative prescription medicines sold in Belgium and Luxembourg across therapeutic areas including oncology, subject to regulatory approval and reimbursement frameworks, and supported by Roche's clinical research collaborations at major Belgian hospitals.
Quantifiable outcome
- Breast cancer medical innovation contributed €53.75 million to Belgian economy
- +1 more outcomes
Companies that use Roche Diagnostics Belgium
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
Roche Diagnostics Belgium technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
AI capability4 records
Feature3 records
Roche Diagnostics Belgium partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered flagship, core and minor.
- Novartis BeLuxflagshipJoint organization of the Belgian-Swiss Health Dialogue at the Swiss Embassy in Brussels, bringing together Roche and Novartis to explore how Belgium and Switzerland can strengthen European competitiveness in life sciences. A comparative report was produced with Inovigate examining best practices from both countries.
- All.Can Belgium - Lung Cancer Working GroupcoreRoche BeLux is a founding member of the All.Can Belgium Lung Cancer Working Group, collaborating to promote efficient lung cancer prevention, care, and treatment solutions in Belgium. The group focuses on improving patient outcomes and ensuring rapid access to innovative treatments.
- Innovative Medicines for Luxembourg (IML)coreRoche is a founding member of IML, which represents the innovative pharmaceutical industry in Luxembourg with over 60 members. IML advocates for faster patient access to innovative medicines through constructive dialogue with government and healthcare stakeholders. Roche actively participates in working groups on public affairs, communication, and market access.
- Pharma.becoreRoche has been a member of Pharma.be since 1969, the representative organization for innovative pharmaceutical industry in Belgium. The company collaborates with industry peers to address challenges, seize opportunities, and shape policies to better serve patients. General Director Marie-José Borst serves on the Pharma.be board and chairs the Public Health Task Force. Over 20 Roche colleagues actively participate in various task forces and focus groups.
- InovigateminorConsultancy that produced a comparative analysis report on life sciences ecosystems in Belgium and Switzerland, examining how the two countries can learn from each other to ensure the future of healthcare innovation in Europe.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Roche Diagnostics Belgium competitors and assessment
Company assessmentDirect peers
- Sanofi Belgium: Sanofi Belgium is the Belgian subsidiary of Sanofi S.A., operating in specialty pharma, vaccines, and rare diseases. Direct peer in the Belgian innovative medicines reimbursement landscape and clinical trial ecosystem.
- Bayer Belgium: Bayer Belgium operates as the Belgian subsidiary of Bayer AG, with pharmaceutical and consumer health divisions. Direct peer in specialty pharma distribution, hospital procurement processes, and Pharma.be industry advocacy in Belgium.
- MSD Belgium: MSD (Merck) Belgium operates as the Belgian arm of Merck & Co., with parallel oncology and specialty pharma offerings. Direct peer for hospital-channel innovative medicines in Belgium, including overlapping immuno-oncology franchises.
- Siemens Healthineers Belgium: Siemens Healthineers Belgium competes in clinical diagnostics and imaging IT in the Belgian hospital market. Direct peer in integrated diagnostics, hospital laboratory solutions, and digital health ecosystems.
- Pfizer Belgium: Pfizer Belgium is the Belgian affiliate of Pfizer Inc., competing across oncology, vaccines, and primary care. Direct peer sharing the same hospital procurement, reimbursement negotiation, and clinical trial placement dynamics in the BeLux market.
- bioMérieux Belgium: bioMérieux Belgium operates in clinical microbiology and in-vitro diagnostics, serving the same Belgian hospital laboratory customers as Roche Diagnostics. Direct peer in decentralized and centralized diagnostics solutions.
- Novartis Belgium: Novartis Belgium is the Belgian subsidiary of Novartis AG, a Swiss global pharma major. Direct peer with overlapping oncology and specialty pharma portfolio, similar hospital-channel sales model, and active BeLux policy advocacy. Notably partners with Roche on the Belgian-Swiss Health Dialogue.
- Abbott Diagnostics Belgium: Abbott Diagnostics competes directly with Roche in the Belgian in-vitro diagnostics market, including the FreeStyle Libre CGM that is encroaching on Roche's Accu-Chek franchise. Most relevant diagnostics-side direct peer.
- GSK Belgium: GSK Belgium is the Belgian affiliate of GSK plc, with active specialty pharma and vaccines franchises. Direct peer sharing Pharma.be membership, similar BeLux commercial footprint, and parallel engagement with Belgian hospital networks.
Broad incumbents
- Philips Healthcare Belgium: Philips Healthcare Belgium operates broadly across medical imaging, patient monitoring, and health informatics. Comparable as a large medtech incumbent serving Belgian hospitals with overlapping health IT and clinical decision support offerings alongside Roche Diagnostics.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Roche Diagnostics Belgium social profiles
Digital presenceRoche Diagnostics Belgium compliance and trust
Trust signalCompliance1 record
Roche Diagnostics Belgium financial estimates
Financial estimateRevenue estimate
Valuation estimate
Roche Diagnostics Belgium leadership team
Management profileNumber of profiles
Profiles2 records
Roche Diagnostics Belgium funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Roche Diagnostics Belgium M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Roche Diagnostics Belgium
What does Roche Diagnostics Belgium do?
Roche Diagnostics Belgium sells in-vitro diagnostic products and solutions covering screening, prevention, diagnosis, and disease monitoring, alongside innovative pharmaceutical medicines addressing unmet medical needs (notably in oncology). The portfolio also includes Roche Diabetes Care Belgium devices such as Accu-Chek blood glucose meters and insulin pumps. The company operates dedicated portals (RochePro, Navify) and a regional customer support center to serve healthcare providers, laboratories, hospitals, and patients across Belgium and Luxembourg.
Is Roche Diagnostics Belgium a public or private company?
Roche Diagnostics Belgium is a private company. It is classified as corporate owned and is currently operating.
When was Roche Diagnostics Belgium founded?
Roche Diagnostics Belgium was founded in 1896. It employs 101 to 250 people.
Where is Roche Diagnostics Belgium based?
Roche Diagnostics Belgium is headquartered in Brussels, Belgium, in the Europe region.
How does Roche Diagnostics Belgium make money?
Three revenue lines are on record. Diagnostic Solutions are the primary driver. The others are pharmaceutical Products and diabetes Care.
Who are Roche Diagnostics Belgium's main competitors?
Direct peers on record are Sanofi Belgium, Bayer Belgium, MSD Belgium, Siemens Healthineers Belgium, Pfizer Belgium, bioMérieux Belgium, Novartis Belgium, Abbott Diagnostics Belgium and GSK Belgium. Philips Healthcare Belgium is listed as a broad incumbent.
Does Roche Diagnostics Belgium have an API?
No public API is recorded for Roche Diagnostics Belgium.
What industry is Roche Diagnostics Belgium in?
Roche Diagnostics Belgium's product category is Clinical Diagnostics. Its primary akta.pro industry code is HLAIACAA, Oncology Specialty Pharmaceuticals, with a secondary code of HLAIAAAJ, Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health). Its NAICS code is 32541 and its SIC code is 2834.